Compare Cadila Healthcare with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs IPCA LABS - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE IPCA LABS CADILA HEALTHCARE/
IPCA LABS
 
P/E (TTM) x 18.3 24.3 75.5% View Chart
P/BV x 2.5 4.7 52.7% View Chart
Dividend Yield % 1.4 0.3 539.4%  

Financials

 CADILA HEALTHCARE   IPCA LABS
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-19
IPCA LABS
Mar-19
CADILA HEALTHCARE/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs4321,042 41.5%   
Low Rs306590 51.9%   
Sales per share (Unadj.) Rs128.6298.6 43.1%  
Earnings per share (Unadj.) Rs18.535.0 53.0%  
Cash flow per share (Unadj.) Rs24.449.4 49.3%  
Dividends per share (Unadj.) Rs3.503.00 116.7%  
Dividend yield (eoy) %0.90.4 257.7%  
Book value per share (Unadj.) Rs101.5247.1 41.1%  
Shares outstanding (eoy) m1,023.74126.35 810.2%   
Bonus/Rights/Conversions -ESOS-  
Price / Sales ratio x2.92.7 105.1%   
Avg P/E ratio x19.923.3 85.4%  
P/CF ratio (eoy) x15.116.5 91.7%  
Price / Book Value ratio x3.63.3 110.3%  
Dividend payout %18.98.6 220.2%   
Avg Mkt Cap Rs m378,170103,108 366.8%   
No. of employees `00012.413.4 92.5%   
Total wages/salary Rs m21,2417,874 269.8%   
Avg. sales/employee Rs Th10,585.02,807.0 377.1%   
Avg. wages/employee Rs Th1,707.8585.8 291.5%   
Avg. net profit/employee Rs Th1,526.5329.0 464.0%   
INCOME DATA
Net Sales Rs m131,65637,732 348.9%  
Other income Rs m2,011577 348.6%   
Total revenues Rs m133,66738,309 348.9%   
Gross profit Rs m29,7316,901 430.8%  
Depreciation Rs m5,9861,824 328.1%   
Interest Rs m1,935189 1,025.4%   
Profit before tax Rs m23,8215,465 435.9%   
Minority Interest Rs m4690-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,3031,042 508.7%   
Profit after tax Rs m18,9874,422 429.4%  
Gross profit margin %22.618.3 123.5%  
Effective tax rate %22.319.1 116.7%   
Net profit margin %14.411.7 123.1%  
BALANCE SHEET DATA
Current assets Rs m84,98123,778 357.4%   
Current liabilities Rs m73,42510,975 669.0%   
Net working cap to sales %8.833.9 25.9%  
Current ratio x1.22.2 53.4%  
Inventory Days Days75104 71.8%  
Debtors Days Days11066 166.1%  
Net fixed assets Rs m133,49320,368 655.4%   
Share capital Rs m1,024253 405.2%   
"Free" reserves Rs m102,83930,971 332.0%   
Net worth Rs m103,86331,224 332.6%   
Long term debt Rs m39,4971,409 2,804.2%   
Total assets Rs m234,83145,507 516.0%  
Interest coverage x13.330.0 44.4%   
Debt to equity ratio x0.40 843.0%  
Sales to assets ratio x0.60.8 67.6%   
Return on assets %8.910.1 87.9%  
Return on equity %18.314.2 129.1%  
Return on capital %18.317.3 105.6%  
Exports to sales %045.9 0.0%   
Imports to sales %016.6 0.0%   
Exports (fob) Rs mNA17,308 0.0%   
Imports (cif) Rs mNA6,266 0.0%   
Fx inflow Rs m48,40417,308 279.7%   
Fx outflow Rs m11,5936,266 185.0%   
Net fx Rs m36,81111,042 333.4%   
CASH FLOW
From Operations Rs m28,8234,923 585.5%  
From Investments Rs m-57,387-1,563 3,671.4%  
From Financial Activity Rs m18,846-1,832 -1,028.7%  
Net Cashflow Rs m-7,1051,528 -465.1%  

Share Holding

Indian Promoters % 74.8 45.9 163.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 11.4 72.8%  
FIIs % 5.9 25.3 23.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 17.4 63.2%  
Shareholders   44,069 36,892 119.5%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   ABBOTT INDIA  JUBILANT LIFE SCIENCES  BIOCON   PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare CADILA HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 181 Points Higher; Energy and Healthcare Stocks Witness Buying(Closing)

Indian share markets continued to trade on a positive note during closing hours but ended their session off day's high.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

IPCA LABS Announces Quarterly Results (2QFY20); Net Profit Up 63.7% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 63.7% YoY). Sales on the other hand came in at Rs 12 bn (up 21.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY20); Net Profit Up 101.5% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 101.5% YoY). Sales on the other hand came in at Rs 10 bn (up 18.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

IPCA LABS Announces Quarterly Results (4QFY19); Net Profit Up 113.4% (Quarterly Result Update)

Jun 3, 2019 | Updated on Jun 3, 2019

For the quarter ended March 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 113.4% YoY). Sales on the other hand came in at Rs 8 bn (up 6.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Nov 20, 2019 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS